Flezar M, Heisler S
Respiratory Health Network of Centres of Excellence, Montreal Chest Hospital Centre, Quebec, Canada.
J Pharmacol Exp Ther. 1993 Jun;265(3):1499-510.
ATP increases intracellular Ca++ ([Ca++]i) by activating different P2-purinoreceptors. Because ATP increases Cl- secretion in cystic fibrosis (CF)-affected epithelia, the current study was designed to establish the link between these two events. Studies were done in epithelial, human MCF-7 breast tumor cells in which the presence of mRNA transcripts encoding CF transmembrane conductance regulator was initially established. Changes in [Ca++]i were measured in single cells by fluorescence microscopy; anion transport was measured by 125I efflux. ATP stimulated concentration-dependent increases in [Ca++]i and 125I efflux from MCF-7 cells. The relative order of agonist potency of various selective P2-purinoreceptor agonists in increasing [Ca++]i and 125I efflux was: UTP > or = ATP > ADP = AMP; 2-chloro-ATP, 2-methylthio-ATP and AMP-phencyclidine were considerably less potent than ATP. The Ca++ ionophore ionomycin increased both intracellular [Ca++]i and 125I secretion. Exposing cells to the intracellular chelator ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetra-acetic acid (EGTA)-acetoxymethylester decreased (AM) decreased ATP- and ionomycin-stimulated 125I efflux. Extracellular EGTA did not alter the Ca++ response to ATP, but inhibited the response to ionomycin. The chelator inhibited both ATP- and ionomycin-induced 125I secretion. Exposure of cells to nifedipine did not affect the responsiveness of MCF-7 cells to ATP. The anion transport antagonist 4,4'-diisothiocyananatostilbene-2,2'-disulfonic acid partially inhibited ATP- and cationophore-stimulated increases in [Ca++]i and 125I secretion. The data suggest that activation of P2 receptors in MCF-7 cells leads to an increase in anion transport as a result of the ability of ATP to increase [Ca++]i; moreover, anion channel antagonists may produce their inhibitory effect on 125I secretion, in part, by blocking agonist-induced intracellular Ca++ signaling.
三磷酸腺苷(ATP)通过激活不同的P2嘌呤受体来增加细胞内钙离子浓度([Ca++]i)。由于ATP可增加囊性纤维化(CF)相关上皮细胞中的氯离子分泌,因此本研究旨在建立这两个事件之间的联系。研究在人MCF-7乳腺肿瘤上皮细胞中进行,最初已确定该细胞中存在编码CF跨膜电导调节因子的mRNA转录本。通过荧光显微镜测量单细胞中[Ca++]i的变化;通过125I外流测量阴离子转运。ATP刺激MCF-7细胞中[Ca++]i和125I外流呈浓度依赖性增加。各种选择性P2嘌呤受体激动剂在增加[Ca++]i和125I外流方面的激动剂效力相对顺序为:尿苷三磷酸(UTP)≥ATP>二磷酸腺苷(ADP)=一磷酸腺苷(AMP);2-氯-ATP、2-甲硫基-ATP和AMP-苯环利定的效力远低于ATP。钙离子载体离子霉素增加细胞内[Ca++]i和125I分泌。将细胞暴露于细胞内螯合剂乙二醇双(β-氨基乙醚)-N,N'-四乙酸(EGTA)-乙酰甲酯(AM)可降低ATP和离子霉素刺激的125I外流。细胞外EGTA不会改变对ATP的钙离子反应,但会抑制对离子霉素的反应。该螯合剂抑制ATP和离子霉素诱导的125I分泌。将细胞暴露于硝苯地平不会影响MCF-7细胞对ATP的反应性。阴离子转运拮抗剂4,4'-二异硫氰酸根合芪-2,2'-二磺酸部分抑制ATP和阳离子载体刺激的[Ca++]i增加和125I分泌。数据表明,MCF-7细胞中P2受体的激活导致阴离子转运增加,这是由于ATP增加[Ca++]i的能力;此外,阴离子通道拮抗剂可能部分通过阻断激动剂诱导的细胞内钙离子信号传导对125I分泌产生抑制作用。